Connect with us

National

AstraZeneca rollout to continue amid probe into Victorian hospitalised with blood clots – The Age

Australia’s AstraZeneca rollout will continue as planned as the country’s medical authorities monitor the first reported case of a rare clotting disorder following…

Published

on

Article feature image

ATAGI has also asked people to be alert for potential severe side effects that occur more than four days after vaccination.
Consumers should be particularly alert to severe, persistent headaches that are different to their usual pattern and do not settle with paracetamol or other painkillers, it said in a statement.
Professor Murphy said in Britain, where more than 18 million people had been given the AstraZeneca vaccine, there were only a few probable cases of blood clots. Britain was also continuing…

Click here to view the original article.